• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大的药物依从性受成本因素的影响。

The effect of cost on adherence to prescription medications in Canada.

机构信息

The Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC.

出版信息

CMAJ. 2012 Feb 21;184(3):297-302. doi: 10.1503/cmaj.111270. Epub 2012 Jan 16.

DOI:10.1503/cmaj.111270
PMID:22249979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3281154/
Abstract

BACKGROUND

Many patients do not adhere to treatment because they cannot afford their prescription medications, putting them at increased risk of adverse health outcomes. We determined the prevalence of cost-related nonadherence and investigated its associated characteristics, including whether a person has drug insurance.

METHODS

Using data from the 2007 Canada Community Health Survey, we analyzed the responses of 5732 people who answered questions about cost-related nonadherence to treatment. We determined the national prevalence of cost-related nonadherence and used logistic regression to evaluate the association between cost-related nonadherence and a series of demographic and socioeconomic variables, including province of residence, age, sex, household income, health status and having drug insurance.

RESULTS

Cost-related nonadherence was reported by 9.6% (95% confidence interval [CI] 8.5%-10.6%) of Canadians who had received a prescription in the past year. In our adjusted model, we found that people in poor health (odds ratio [OR] 2.64, 95% CI 1.77-3.94), those with lower income (OR 3.29, 95% CI 2.03-5.33), those without drug insurance (OR 4.52, 95% CI 3.29-6.20) and those who live in British Columbia (OR 2.56, 95% CI 1.49-4.42) were more likely to report cost-related nonadherence. Predicted rates of cost-related nonadherence ranged from 3.6% (95% CI 2.4-4.5) among people with insurance and high household incomes to 35.6% (95% CI 26.1%-44.9%) among people with no insurance and low household incomes.

INTERPRETATION

About 1 in 10 Canadians who receive a prescription report cost-related nonadherence. The variability in insurance coverage for prescription medications appears to be a key reason behind this phenomenon.

摘要

背景

许多患者因负担不起处方药物而无法坚持治疗,从而增加了不良健康后果的风险。我们确定了与费用相关的不依从的流行率,并调查了其相关特征,包括是否有药物保险。

方法

我们使用 2007 年加拿大社区健康调查的数据,分析了 5732 名回答与治疗相关的费用相关不依从问题的人的回答。我们确定了与费用相关的不依从的全国流行率,并使用逻辑回归评估了与一系列人口统计学和社会经济变量(包括居住省份、年龄、性别、家庭收入、健康状况和药物保险)之间的关联。

结果

在过去一年中接受过处方的加拿大人中,有 9.6%(95%置信区间 [CI] 8.5%-10.6%)报告存在与费用相关的不依从。在我们调整后的模型中,我们发现健康状况较差的人(比值比 [OR] 2.64,95%CI 1.77-3.94)、收入较低的人(OR 3.29,95%CI 2.03-5.33)、没有药物保险的人(OR 4.52,95%CI 3.29-6.20)和居住在不列颠哥伦比亚省的人(OR 2.56,95%CI 1.49-4.42)更有可能报告与费用相关的不依从。从有保险和高家庭收入的人群中,预计与费用相关的不依从率为 3.6%(95%CI 2.4-4.5),到没有保险和低家庭收入的人群中,预计这一比率为 35.6%(95%CI 26.1%-44.9%)。

解释

大约每 10 名接受处方的加拿大人中就有 1 人报告存在与费用相关的不依从。处方药物保险覆盖范围的差异似乎是造成这种现象的一个关键原因。

相似文献

1
The effect of cost on adherence to prescription medications in Canada.加拿大的药物依从性受成本因素的影响。
CMAJ. 2012 Feb 21;184(3):297-302. doi: 10.1503/cmaj.111270. Epub 2012 Jan 16.
2
Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.美国和加拿大与费用相关的处方不依从性:使用2007年七国国际卫生政策调查进行的系统层面比较。
Clin Ther. 2009 Jan;31(1):213-9. doi: 10.1016/j.clinthera.2009.01.006.
3
A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.一项关于因费用导致的处方不依从性的跨国研究:来自加拿大-美国健康联合调查的数据。
Clin Ther. 2006 Aug;28(8):1217-1224. doi: 10.1016/j.clinthera.2006.07.009.
4
Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.加拿大慢性病患者的药品和药品支出以及与成本相关的处方不依从情况。
Health Rep. 2016 Jun 15;27(6):3-8.
5
Cost-related medication nonadherence in older patients with rheumatoid arthritis.老年类风湿关节炎患者与费用相关的药物不依从。
J Rheumatol. 2013 Feb;40(2):137-43. doi: 10.3899/jrheum.120441. Epub 2013 Jan 15.
6
Cost-related medication nonadherence among over-indebted individuals enrolled in statutory health insurance in Germany: a cross-sectional population study.德国法定健康保险中负债人群的与费用相关的药物不依从性:一项横断面人群研究。
BMC Health Serv Res. 2019 Nov 26;19(1):887. doi: 10.1186/s12913-019-4710-0.
7
A pilot study on cost-related medication nonadherence in Ontario.安大略省与费用相关的药物治疗不依从性的一项试点研究。
J Popul Ther Clin Pharmacol. 2012;19(2):e239-47. Epub 2012 Jul 12.
8
Prescription Drug Insurance and Cost-Related Medication Nonadherence Among Lesbian, Gay, and Bisexual Individuals in Canada.加拿大女同性恋、男同性恋和双性恋者的处方药保险与药物费用相关的不依从性。
LGBT Health. 2022 Aug-Sep;9(6):426-435. doi: 10.1089/lgbt.2021.0273. Epub 2022 May 10.
9
Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.私人药品保险计划覆盖的患者的报销时间和自付费用对药物依从性的影响。
J Manag Care Spec Pharm. 2016 May;22(5):539-47. doi: 10.18553/jmcp.2016.22.5.539.
10
Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.医疗保险处方药计划中终末期肾病患者与药物费用相关的不遵医嘱用药情况。
Am J Health Syst Pharm. 2011 Jul 15;68(14):1339-48. doi: 10.2146/ajhp100400.

引用本文的文献

1
Universal Pharmacare and Contraceptive Dispensations Among Youth.青少年中的全民医保与避孕药具发放
JAMA Pediatr. 2025 Aug 18. doi: 10.1001/jamapediatrics.2025.2585.
2
Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.全民免费覆盖对长效可逆避孕法及所有处方避孕法使用情况的影响:基于人群的对照中断时间序列分析
BMJ. 2025 Jul 28;390:e083874. doi: 10.1136/bmj-2024-083874.
3
Predictors of cost-related medication nonadherence in Canada: a repeated cross-sectional analysis of the Canadian Community Health Survey.加拿大与费用相关的药物不依从性的预测因素:加拿大社区健康调查的重复横断面分析。
CMAJ. 2024 Nov 24;196(40):E1331-E1340. doi: 10.1503/cmaj.241024.
4
GLP-1 Agonism for Kidney Transplant Recipients: A Narrative Review of Current Evidence and Future Directions Across the Research Spectrum.胰高血糖素样肽-1激动剂用于肾移植受者:对当前证据及整个研究领域未来方向的叙述性综述
Can J Kidney Health Dis. 2024 Oct 31;11:20543581241290317. doi: 10.1177/20543581241290317. eCollection 2024.
5
Role of the pharmacist caring for people at risk of or living with HIV in Canada.加拿大药剂师在照顾有感染艾滋病毒风险或感染艾滋病毒的人群方面的作用。
Can Pharm J (Ott). 2024 Aug 2;157(5):218-239. doi: 10.1177/17151635241267350. eCollection 2024 Sep-Oct.
6
A retrospective analysis of e-prescriptions for non-communicable diseases on a telehealth platform in Malaysia.马来西亚远程医疗平台上非传染性疾病电子处方的回顾性分析。
BMC Health Serv Res. 2024 Aug 6;24(1):897. doi: 10.1186/s12913-024-11341-0.
7
Longitudinal study of the impact of the COVID-19 pandemic on diet and physical activity among Latinos of Mexican ancestry.COVID-19 大流行对祖籍墨西哥的拉丁裔饮食和体育活动影响的纵向研究。
J Transl Med. 2024 Apr 9;22(1):342. doi: 10.1186/s12967-024-05007-y.
8
Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients.与绝经前乳腺癌患者内分泌治疗依从模式相关的临床因素。
Breast Cancer Res. 2024 Apr 8;26(1):59. doi: 10.1186/s13058-024-01819-4.
9
Underprescription of Fibrate Among Patients With Diabetic Retinopathy in Perak, Malaysia.马来西亚霹雳州糖尿病视网膜病变患者贝特类药物处方不足情况
Cureus. 2024 Jan 1;16(1):e51434. doi: 10.7759/cureus.51434. eCollection 2024 Jan.
10
An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone.一种可选的脱钩奖励制度:让药物创新造福所有人。
Appl Health Econ Health Policy. 2024 Mar;22(2):155-164. doi: 10.1007/s40258-023-00860-2. Epub 2023 Dec 22.

本文引用的文献

1
Can Canada get on with national pharmacare already?加拿大能否已经推行全民药物保险计划?
CMAJ. 2011 Dec 13;183(18):E1275. doi: 10.1503/cmaj.110643. Epub 2011 Apr 26.
2
How health insurance design affects access to care and costs, by income, in eleven countries.医疗保险设计如何影响十一个国家按收入划分的医疗服务可及性和成本。
Health Aff (Millwood). 2010 Dec;29(12):2323-34. doi: 10.1377/hlthaff.2010.0862. Epub 2010 Nov 18.
3
Costs and benefits of free medications after myocardial infarction.心肌梗死后免费药物的成本与效益
Healthc Policy. 2009 Nov;5(2):68-86.
4
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.医疗保险D部分实施后与费用相关的药物治疗不依从性及基本需求支出
JAMA. 2008 Apr 23;299(16):1922-8. doi: 10.1001/jama.299.16.1922.
5
Toward higher-performance health systems: adults' health care experiences in seven countries, 2007.迈向更高绩效的卫生系统:2007年七个国家成年人的医疗保健经历
Health Aff (Millwood). 2007 Nov-Dec;26(6):w717-34. doi: 10.1377/hlthaff.26.6.w717.
6
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.处方药费用分担:与药物使用、医疗利用、支出及健康的关联
JAMA. 2007 Jul 4;298(1):61-9. doi: 10.1001/jama.298.1.61.
7
Patients at-risk for cost-related medication nonadherence: a review of the literature.与费用相关的药物治疗不依从风险患者:文献综述
J Gen Intern Med. 2007 Jun;22(6):864-71. doi: 10.1007/s11606-007-0180-x. Epub 2007 Apr 5.
8
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.老年及残疾医疗保险受益人与费用相关的药物治疗不依从情况:医疗保险药品福利实施前一年的全国性调查
Arch Intern Med. 2006 Sep 25;166(17):1829-35. doi: 10.1001/archinte.166.17.1829.
9
A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.一项关于因费用导致的处方不依从性的跨国研究:来自加拿大-美国健康联合调查的数据。
Clin Ther. 2006 Aug;28(8):1217-1224. doi: 10.1016/j.clinthera.2006.07.009.
10
Adherence to medication.药物依从性
N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100.